Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Pediatric Blood & Cancer|September 4, 2025
Dental Adverse Effects Following Multimodality Treatment for Head and Neck Rhabdomyosarcoma: Results of a Trans-Atlantic Multicentre StudyKoen B Krommenhoek, Marinka L F Hol, Olga Slater, et al.Cancer Medicine|October 8, 2022
Patient-reported outcomes in childhood head and neck rhabdomyosarcoma survivors and their relation to physician-graded adverse events-A multicenter study using the FACE-Q Craniofacial moduleMichèle Morfouace, Marinka L F Hol, Reineke A Schoot, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 4, 2026
Dose-effect analysis of facial bone morphology following radiation therapy for head and neck rhabdomyosarcomaMarinka L F Hol, Michael Suttie, Mark N Gaze, et al.Pediatric Blood & Cancer|April 20, 2017
Facial asymmetry in head and neck rhabdomyosarcoma survivorsReineke A Schoot, Marinka L F Hol, Johannes H M Merks, et al.Facial Plastic Surgery & Aesthetic Medicine|April 7, 2021
Psychometric Validation of the FACE-Q Craniofacial Module for Facial Nerve ParalysisAnne F Klassen, Charlene Rae, Lucas Gallo, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 19, 2019
AMORE treatment as salvage treatment in children and young adults with relapsed head-neck rhabdomyosarcomaBas Vaarwerk, Marinka L F Hol, Reineke A Schoot, et al.European Journal of Endocrinology|January 8, 2025
Endocrine dysfunction in long-term survivors of pediatric head and neck rhabdomyosarcomaMichele Morfouace, Reineke A Schoot, Marinka L F Hol, et al.Pediatric Blood & Cancer|May 30, 2023
Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans-Atlantic, multicenter cross-sectional cohort studyMarinka L F Hol, Daniel J Indelicato, Olga Slater, et al.Head & Neck|November 15, 2024
Parameningeal Rhabdomyosarcoma: Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 StudyReineke A Schoot, Pieter Taselaar, Giovanni Scarzello, et al.Frontiers in Pediatrics|June 8, 2026
DENTALE: a validated Dentofacial EvaluatioN Tool to standardize radiological Assessment of Late dental and maxillofacial adverse Effects following treatment for pediatric rhabdomyosarcomaKoen B Krommenhoek, Reinier C Hoogeveen, E Foster-Thomas, et al.Pageof 3